BlackRock, Inc. 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-28 1:02 pm Sale |
2025-03-31 | 13G | Vir Biotechnology, Inc. VIR |
BlackRock Inc. BLK |
14,826,039 10.800% |
-2,038,540 (-12.09%) |
Filing |
| 2024-01-23 4:14 pm Purchase |
2023-12-31 | 13G | Vir Biotechnology, Inc. VIR |
BlackRock Inc. BLK |
16,864,579 12.500% |
2,727,951 (+19.30%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Vir Biotechnology, Inc. VIR |
BlackRock Inc. BLK |
14,136,628 10.600% |
752,434 (+5.62%) |
Filing |
| 2022-09-08 1:43 pm Purchase |
2022-08-31 | 13G | Vir Biotechnology, Inc. VIR |
BlackRock Inc. BLK |
13,384,194 10.100% |
13,384,194 (New Position) |
Filing |